Ignite Creation Date:
2024-05-06 @ 4:30 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05003141
Status:
UNKNOWN
Last Update Posted:
2022-03-28
First Post:
2021-07-20
Brief Title:
PSB202 in Patients With Previously Treated- Relapsed- Indolent B-Cell Malignancies
Sponsor:
Qilu Puget Sound Biotherapeutics dba Sound Biologics
Organization:
Qilu Puget Sound Biotherapeutics dba Sound Biologics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MALT Lymphoma |
| Follicular Lymphoma |
| Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma |
| Waldenstrom Macroglobulinemia |
| Marginal Zone Lymphoma |
| Mantle Cell Lymphoma |
| Indolent Lymphoma |
| Refractory B-Cell Lymphoma |